Navigation Links
Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine
Date:2/7/2008

WALTHAM, Mass., Feb. 7 /PRNewswire/ -- Logical Therapeutics, Inc., a biotechnology company focused on the development of medicines that treat diseases associated with poorly controlled inflammation, announced today that its co-founder and CEO Mitchell P. Fink M.D. was presented with the Distinguished Investigator Award from the American College of Critical Care Medicine during the 37th Critical Care Congress of the Society of Critical Care Medicine held February 2-6 in Honolulu, Hawaii.

The prestigious recognition was awarded to Dr. Fink for his pioneering research related to the pathogenesis and treatment of sepsis, a serious medical condition characterized by widespread inflammation, due to infection.

Dr. Fink was the Founding Chairman of the Department of Critical Care Medicine at the University of Pittsburgh, the first such department at a medical school in the United States. Dr Fink also held other University appointments including Professor of Pharmacology, the Watson Professor of Surgery, and Associate Vice-chancellor for Translational Research. Dr. Fink's academic research program was continuously funded by the National Institutes of Health for more than 20 years.

The Society of Critical Care Medicine, which bestowed the honor to Dr. Fink, is the leading professional organization dedicated to ensuring excellence and consistency in the practice of critical care medicine. With more than 13,000 members worldwide, the Society is the only professional organization devoted exclusively to the advancement of multi-professional intensive care through excellence in patient care, professional education, public education, research and advocacy.

Dr. Fink is an author or co-author of more than 250 peer-reviewed scientific publications, has edited or co-edited 13 textbooks and is currently an Associate Editor for two highly regarded scientific journals: the Journal of Pharmacology and Experimental Therapeutics and the Journal of Leukocyte
'/>"/>

SOURCE Logical Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
2. Neurobiological Technologies Sets Date for Second Quarter Financial Results
3. Montana State University lab gives early warnings about biological invaders
4. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
5. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
6. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
7. The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract
8. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
9. Neurobiological Technologies Announces Pricing of Its $60 Million Common Stock Offering
10. Microtest Offers Free White Paper: Virus Testing for Biological Products: Partnering With a Contract Lab
11. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).../PRNewswire-FirstCall/ - Microbix Biosystems Inc. ...ed the Form 52-109F1 Certification of Annual Filin...and James Long, the Chief Financial Officer (the "... connection with the annual audited financial stat..., The Company initially filed the annual financial...
(Date:11/6/2009)...., Nov. 6 ,, 3Q09 ...of Qutenza(TM) E.U. Marketing Authorization to Ast...ss in commercial readiness activities Expanded ma..., Marketing; and Director, Commercial Operations ... and Audit Committee chairman , Upcoming 20...
(Date:11/5/2009)... Gone hybrid . . . , Fuel economy ratings for ... at the www.fueleconomy.gov web site, which Oak ...for the U.S. Department of Energy and the U.S. Env...ehicles on the best fuel economy list are hybrid e... highway). "This list proves that hybrids have gon...
(Date:11/5/2009)...Calif., Nov. 5 ThermoGen... innovative products for processing and storing ad...st quarter of fiscal 2010. ,, For the quarter e...nues of $5.2 million, a 15 percent increase over r...r ago. The Company said the key contributors to th...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...n. 7 Abaxis, Inc. (Nasdaq: ABAX ), a medical pr...nalysis instruments for both the medical and veter... into a license agreement for co-exclusive worldwi...s in the professional marketplace for certain tech...vices and methods. , , This license agreement pro...
...an. 6 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman...otechnology, and medical device,research and devel...a and the,United States, today announced that Dr. ...Officer, will present at the 27th Annual J.P. Morg...009, at 4:30 pm Pacific,Standard Time. , (Logo...
...Jan. 6 InterMune, Inc.,(Nasdaq: ITMN ) today an...utive,Officer and President of InterMune, will pre...ference in San Francisco on January 15, 2009 at 1:...of the presentation, investors and other,intereste...e of InterMune,s,corporate website at http://www....
Other Biology Technology:ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 2ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 3WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference 2
(Date:11/4/2009)... HILL Scientists at the University of North Carol...ersity of California, San Francisco have developed...new target diseases for existing drugs. , The re...mpares how similar the structures of all known dru... -- known as ligands -- of disease targets within ...
(Date:11/4/2009)...Nov. 4 Glencoe Software, Inc., the... (OME) Consortium ( http://openmicroscopy.org ),...merican Society of Cell Biology,s exciting new pro... has been awarded a $2.5M stimulus grant through t...ortunities program, as part of the American Reinve...
(Date:11/3/2009)...ON, FL (November 4, 2009) For more than 25 years,...onch ( Strombus gigas ) have been unsuccessfulunti...eeding techniques to produce beaded (nucleated) an...have been developed by scientists from Florida Atl...titute (HBOI). With less than two years of researc...
Breaking Biology News(10 mins):Study points to new uses, unexpected side effects of already existing drugs 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 1Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 2Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 3Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 4Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 5CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 1CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 2CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 3CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 4CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 5CREON 28R 29 28pancrelipase 29 Delayed Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis 5698 6New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 1New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 2New Study Results Analyzed the Use of KAPIDEX 28TM 29 28dexlansoprazole 29 for Nighttime Heartburn in Adults with Non Erosive GERD 5694 3
...ew way to assess the potentially damaging effects ...also be used to monitor a fetus,s response to ther...dical imaging tools. Scientists at the U.S. Depart...hose findings are reported in the February issue o...lear Medicine, used positron emission tomography (...
...replicating, mineralizing agent, has been identifi...n (NASA) scientists as a potential culprit in kidn...ntial for future exploratory space missions to the...he elements of outer space, health is a major conc...plications of NB, trials were conducted at NASA to...
...fering from Traveler,s Diarrhea , Norovirus may b... United States citizens returning from Mexico and ..., Mexico and Sweden. Their findings appear in the ...iology. , It is estimated that 20 to 50 percent of...ld will experience traveler,s diarrhea (TD). TD, d...
Other Biology News:PET/MRI scans may help unravel mechanisms of prenatal drug damage 2PET/MRI scans may help unravel mechanisms of prenatal drug damage 3PET/MRI scans may help unravel mechanisms of prenatal drug damage 4Norovirus, AIDS vaccine and Hepatitis Virus 2Norovirus, AIDS vaccine and Hepatitis Virus 3
...sera are specifically depleted of a single complem...otein, the alternative and classical pathways are ...r the detection and quantitation of hemolytically ...been used to assess complement activation in non-h...
...-2000, except that it uses a deep-UV deuterium bul...d comes with a shutter (controlled via a TTL signa...roduces a powerful, stable output from 215-400 nm.... are available, providing a wavelength range of 19...
...A is a fully automated microplate based multi-dete...ia and industry. The FLUOstar incorporates four di...nsity including FRET and multilabel applications ...igh-Performance Luminescence (flash and glow) ded...
Safety Glasses Dispensers from Terra Universal, Inc.
Biology Products: